Insider track record Other Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Neil Falkingham. Officer active across 1 company, notably GSK plc. Aggregated, 28 reports have been published. Activity tracked since 12 January 2026. The latest transaction was disclosed on 11 August 2026 (Purchase). Regulator: RNS (LSE). The full history is free.
Companies and markets linked to Neil Falkingham Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations 28 total
● PCA of Lynn Baxter (President, Europe) · Executives · 11 Aug 2026 · GSK plc 14 shares @ £19.3493 ISIN ISIN GB00BN7SWP63RNS:9721245-8 ● PCA of Lynn Baxter (President, Europe) · Executives · 11 Aug 2026 · GSK plc 14 shares @ £19.3493 0.0000% mcap 0.1% of flow ISIN ISIN GB00BN7SWP63FCA-NSM:802aebe3-75c1-4ba5-8333-3c8ccb6de1b0-8 ● PCA of Lynn Baxter (President, Europe) · Executives · 9 Jul 2026 · GSK plc 0
ISIN ISIN GB00BN7SWP63RNS:9668630-11 ● PCA of Lynn Baxter (President, Europe) · Executives · 13 Jul 2026 · GSK plc 6 shares @ £19.755 0.0000% mcap 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:9668630-14 ● PCA of Lynn Baxter (President, Europe) · Executives · 9 Jul 2026 · GSK plc 0
ISIN ISIN GB00BN7SWP63RNS:0920c70b-f075-4c99-aba0-46720a29730a-11 ● PCA of Lynn Baxter (President, Europe) · Executives · 9 Jul 2026 · GSK plc 12 shares @ £19.6292 0.0000% mcap 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:9666294-8 ● PCA of Lynn Baxter (President, Europe) · Executives · 9 Jul 2026 · GSK plc 57 shares @ £19.6289 0.0001% mcap 0.2% of flow ISIN ISIN GB00BN7SWP63RNS:9666294-17 ● PCA of Lynn Baxter (President, Europe) · Executives · 9 Jul 2026 · GSK plc 12 shares @ £19.6292 0.0000% mcap 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:06e0a094-373b-4460-b97c-91525b0dd5d9-8 ● PCA of Lynn Baxter (President, Europe) · Executives · 9 Jul 2026 · GSK plc 57 shares @ £19.6289 0.0001% mcap 0.2% of flow ISIN ISIN GB00BN7SWP63RNS:06e0a094-373b-4460-b97c-91525b0dd5d9-17 ● PCA of Lynn Baxter (President, Europe) · Executives · 9 Jun 2026 · GSK plc 12 shares @ £18.8392 0.0000% mcap 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:9614374-8 ● PCA of Lynn Baxter (President, Europe) · Executives · 9 Jun 2026 · GSK plc 12 shares @ £18.8392 0.0000% mcap 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:03338973-0058-4811-9fe5-7b22157346a2-8 ● PCA of Lynn Baxter (President, Europe) · Executives · 12 May 2026 · GSK plc 14 shares @ £18.778 0.0000% mcap 100.0% of flow ISIN ISIN GB00BN7SWP63RNS:9569357-8 ● PCA of Lynn Baxter (President, Europe) · Executives · 12 May 2026 · GSK plc 14 shares @ £18.6557 0.0000% mcap 0.1% of flow ISIN ISIN GB00BN7SWP63RNS:eaad27f1-a91f-4bc4-815a-149202956de0-8 ● PCA of Lynn Baxter (President, Europe) · Executives · 13 Apr 2026 · GSK plc 12 shares @ £21.7083 0.0000% mcap 0.1% of flow ISIN ISIN GB00BN7SWP63RNS:bae2311e-28b0-4835-a894-0209eedccba9-8 ● PCA of Lynn Baxter (President, Europe) · Executives · 9 Apr 2026 · GSK plc 0
ISIN ISIN GB00BN7SWP63RNS:66208821-3d67-43ba-837e-411f45d449f1-15 ● PCA of Lynn Baxter (President, Europe) · Executives · 10 Apr 2026 · GSK plc 6 shares @ £21.6967 0.0000% mcap 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:66208821-3d67-43ba-837e-411f45d449f1-3 ● PCA of Lynn Baxter (President, Europe) · Executives · 9 Apr 2026 · GSK plc 54 shares @ £21.3387 0.0000% mcap 0.2% of flow ISIN ISIN GB00BN7SWP63RNS:5b5d692c-e307-4a46-a436-f5464b4ee34b-9 ● PCA of Lynn Baxter (President, Europe) · Executives · 10 Mar 2026 · GSK plc 12 shares @ £20.7167 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:08be650c-10c4-4fa5-9cae-5b89efa04716-8 ● PCA of Lynn Baxter (President, Europe) · Executives · 13 Feb 2026 · GSK plc 10,908 shares 0
ISIN ISIN GB00BN7SWP63RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-28 ● PCA of Lynn Baxter (President, Europe) · Executives · 13 Feb 2026 · GSK plc 5,259 shares @ £21.6002 22.4% of flow ISIN ISIN GB00BN7SWP63RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-29 ● PCA of Lynn Baxter (President, Europe) · Executives · 12 Feb 2026 · GSK plc 11,800 shares @ £21.41 49.9% of flow ISIN ISIN GB00BN7SWP63RNS:586c5c74-54b9-425a-a37c-ba21836ecce7-15 ● PCA of Lynn Baxter (President, Europe) · Executives · 10 Feb 2026 · GSK plc 12 shares @ £21.7917 0.1% of flow ISIN ISIN GB00BN7SWP63RNS:f7024c14-f781-4e48-a904-495085bc7ca2-8 ● PCA of Lynn Baxter (President, Europe) · Executives · 9 Feb 2026 · GSK plc 4,373 shares @ £21.9082 19.0% of flow ISIN ISIN GB00BN7SWP63RNS:b9b234f0-beb3-4926-b79e-ff2ce727c5dd-11 ● PCA of Lynn Baxter (President, Europe) · Executives · 9 Feb 2026 · GSK plc 10,050 shares 0
ISIN ISIN GB00BN7SWP63RNS:b9b234f0-beb3-4926-b79e-ff2ce727c5dd-10 ● PCA of Lynn Baxter (President, Europe) · Executives · 5 Feb 2026 · GSK plc 2,000 shares @ £20.87 8.3% of flow ISIN ISIN GB00BN7SWP63RNS:c409022d-25c5-4968-9022-97e323559e34-1 25 of 28 declarations
Load more (3 remaining) About Neil Falkingham Neil Falkingham is a declarant linked to GSK plc as PCA of Lynn Baxter (President, Europe). Across 25 filings, all 25 are included in the most recent sample, covering 2026-01-13 to 2026-07-15, with EUR 7,922 of buys and EUR 288,829 of sells; the most common transaction nature is Purchase.